ZINNAT 250 mg, film-coated tablet 8 tablets
Active ingredients: Cefuroxime, Cefuroxime axetil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINNAT 250 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 8 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Angines (celles provoquées par des streptocoques hémolytiques)<br>- Pharyngites (celles provoquées par des streptocoques hémolytiques)<br>- otites (dites "moyennes aiguës")<br>- Sinusites<br>- Bronchites chroniques en phase exacerbée ; JOURNAL OFFICIEL ; 19/04/94
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1988
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69634836CIP73312148CIP133400933121488Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME AXÉTILcomprimé | — | SA |
| CÉFUROXIMEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.